カテゴリ： MarketLine, 企業調査, 日本

Furukawa Co., Ltd.：企業の戦略・SWOT・財務情報

◆英語タイトル：Furukawa Co., Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C5655
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：37
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：金属・鉱業
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Furukawa Co., Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Furukawa Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Furukawa Co Ltd (Furukawa or ‘the group’) offers diverse products in the fields of machinery and materials through its subsidiaries. The group operates through seven business segments: Metals, Rock Drills Machinery, UNIC Machinery, Industrial Machinery, Chemicals, Electronic Materials, and Real Estate. Furukawa primarily operates in Japan where is headquartered in Tokyo, Japan.

Scope

- Detailed information on Furukawa Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Furukawa Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Furukawa Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Furukawa Co., Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Furukawa Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Furukawa Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Furukawa Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Furukawa Co., Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Furukawa Co Ltd: Company Overview 8
Furukawa Co Ltd: Overview and Key Facts 8
Furukawa Co Ltd: Overview 8
Furukawa Co Ltd: Key Facts 8
Furukawa Co Ltd: Key Employees 10
Furukawa Co Ltd: Major Products and Services 12
Furukawa Co Ltd: Company History 14
Furukawa Co Ltd: Management Statement 18
Furukawa Co Ltd: Locations and Subsidiaries 20
Furukawa Co Ltd: Key Competitors 22
Furukawa Co Ltd: Company Analysis 23
Furukawa Co Ltd: Business Description 23
Furukawa Co Ltd: SWOT Analysis 25
Furukawa Co Ltd: SWOT Overview 25
Furukawa Co Ltd: Strengths 25
Furukawa Co Ltd: Weaknesses 27
Furukawa Co Ltd: Opportunities 27
Furukawa Co Ltd: Threats 28
Furukawa Co Ltd: Corporate Financial Deals Activity 30
Furukawa Co Ltd: Financial Deals Overview 30
Furukawa Co Ltd: Top Deals 2014 – 2018YTD* 31
Furukawa Co Ltd: Divestments 32
Furukawa Co Ltd: Recent Developments 33
Furukawa Co Ltd: News and Events Summary 33
Furukawa Co Ltd: Financial Performance 33
Appendix 35
Contact Us 35
Methodology 35
About MarketLine 36

List of Tables
Table 1: Furukawa Co Ltd: Key Facts
Table 2: Furukawa Co Ltd: Key Employees
Table 3: Furukawa Co Ltd: Company History
Table 4: Furukawa Co Ltd: Locations and Subsidiaries
Table 5: Furukawa Co Ltd: Key Competitors
Table 6: Furukawa Co Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Furukawa Co Ltd: Top Deals 2014 - 2018YTD*
Table 8: Furukawa Co Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 9: Furukawa Co Ltd: Divestments by Geography (2014 - YTD*2018)
Table 10: Furukawa Co Ltd: News and Events Summary
Table 11: Furukawa Co Ltd: Financial Performance

List of Figures
Figure 1: Furukawa Co Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Furukawa Co Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 3: Furukawa Co Ltd: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Furukawa Co., Ltd.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Petro Matad Ltd (MATD)：企業の財務・戦略的SWOT分析
    Summary Petro Matad Ltd (Petro Matad) is an oil and gas company that develops and operates oil and gas exploration properties. The company’s upstream oil and gas exploration asset base includes Block IV, Block XX, and Block V. Its Block XX is located in the far eastern part of Mongolia producing oil …
  • Macy’s Inc：戦略・SWOT・企業財務分析
    Macy's Inc - Strategy, SWOT and Corporate Finance Report Summary Macy's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Heinzel Holding GmbH：企業の戦略的SWOT分析
    Heinzel Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Compugen Ltd (CGEN)-製薬・医療分野：企業M&A・提携分析
    Summary Compugen Ltd (Compugen) is a drug discovery company that develops medicines for immuno-oncology and autoimmune diseases. The company’s immuno-oncology pipeline comprises CGEN-15001T, CGEN-15022, CGEN-15022, CGEN-15029, target candidates, immuno-modulatory target candidates and ADC target can …
  • Vascular Biogenics Ltd (VBLT)：企業の財務・戦略的SWOT分析
    Summary Vascular Biogenics Ltd (VBL) is a clinical biopharmaceutical company that discovers, develops and commercializes treatments for cancer. The company’s product pipeline includes VB-111. VBL’s product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for ca …
  • Brokk AB：企業の戦略的SWOT分析
    Brokk AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Gelita AG：企業の戦略・SWOT・財務情報
    Gelita AG - Strategy, SWOT and Corporate Finance Report Summary Gelita AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Corgenix Medical Corp-医療機器分野：企業M&A・提携分析
    Summary Corgenix Medical Corp (Corgenix), a subsidiary of Orgentec Diagnostika GmbH is a medical device company that offers medical diagnostic solutions. The company offers vascular disease products, infectious disease products, non-invasive liver biomarkers, and instrumentation. It offers an instru …
  • Innogy SE (IGY)：電力：M&Aディール及び事業提携情報
    Summary Innogy SE (Innogy), a subsidiary of RWE AG, is an energy company. The company offers electricity and natural gas. It operates through its business segments such as renewables, grid and infrastructure, and retail. Innogy’s company’s grid and infrastructure segment operates electricity and gas …
  • Carl Zeiss Meditec Inc.：医療機器：M&Aディール及び事業提携情報
    Summary Carl Zeiss Meditec Inc (Carl Zeiss Meditec), a subsidiary of Carl Zeiss Meditec AG is a medical technology company that manufactures and markets various healthcare products. The company provides ophthalmology and optometry products, neurosurgery products, ENT products, spine surgery products …
  • Double Bond Pharmaceutical International AB (DBPB)：製薬・医療：M&Aディール及び事業提携情報
    Summary Double Bond Pharmaceutical International AB (DBP) is a pharmaceutical company that design, develop and commercialize therapies for cancer and autoimmune diseases. The company’s product pipeline includes SI-053 (Temodex), a novel therapy to treat malignant brain tumors; SA-033, SA-042, and SA …
  • Co-Diagnostics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • Wolverine World Wide, Inc.：企業の戦略・SWOT・財務情報
    Wolverine World Wide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wolverine World Wide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bauer AG (B5A)：企業の財務・戦略的SWOT分析
    Bauer AG (B5A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Banco Santander SA：戦略・SWOT・企業財務分析
    Banco Santander SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Clean Harbors, Inc. (CLH)：企業の財務・戦略的SWOT分析
    Clean Harbors, Inc. (CLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • F5 Networks, Inc. (FFIV)：企業の財務・戦略的SWOT分析
    F5 Networks, Inc. (FFIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Merck & Co., Inc.：企業の戦略・SWOT・財務情報
    Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nuvelution Pharma Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Nuvelution Pharma Inc (Nuvelution Pharma) is a developer of late-stage clinical assets. The company offers research and development risk-sharing approach to pharmaceutical and biotechnology companies. It facilitates advancement of late-stage clinical assets where research and development bud …
  • Veritas (India) Ltd：企業の戦略・SWOT・財務分析
    Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆